NCT07044479View on ClinicalTrials.gov

A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 3, 2025

Primary Completion Date

August 13, 2025

Study Completion Date

August 28, 2025

Conditions

Healthy

Interventions

DRUG

Enlicitide

Single dose of enlicitide is administered orally on day 1 of each testing period

Trial Locations (1)

85283

Celerion, Inc. ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY